Olema pharmaceuticals inc.

Major-Pharmaceuticals

OLMA


Executive/
Director

Price

  • Last Close
  • $ 5.9
    $ +0.34 6.12 %
    Jan 3, 2025
  • 52-Week High/Low
  • $17.14 - $9.61
  • YTD
  • 1.1%

  • Trading Volume
  • 18,136
  • Market Cap Full
  • $ 323.1M
  • Shares Outstanding
  • 54.8M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -39% -56.1% 41.6% -19.4% 1.1%
Q2 - - - - 4% -8.7% -2.4% 160.2% 2.9% -
Q3 - - - - 8% -1.5% -32.2% 36.8% -28.7% -
Q4 - - - - 2.5% -65.6% -11.2% 20.3% -38.2% -
J F M A M J J A S O N D
2025 1.1% - - - - - - - - - - -
2024 -7.1% -4.9% -8.8% -12.8% -1.7% 15.6% 44.6% -28.7% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-81%-74%473%-58%1%

Earnings

2019 2020 2021 2022 2023
Q1 - - -0.39 -0.58 -0.70
Q2 - - -0.42 -0.82 -0.49
Q3 - - -0.45 -0.57 -0.48
Q4 - - -0.54 -0.65 -
A -1.7 -3.4 -1.8 -2.6 -1.67

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 40.3 40.6
Jun 40.2 40.4 40.8
Sep 39.6 40.4 41.4
Dec 40.3 40.5 54.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 53.5 - - - -
Equity multiplier - - - - -